Your browser doesn't support javascript.
loading
Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder.
Ho, Ming-Fen; Zhang, Cheng; Moon, Irene; Coombes, Brandon J; Biernacka, Joanna; Skime, Michelle; Choi, Doo-Sup; Croarkin, Paul E; Frye, Mark A; Ngo, Quyen; Skillon, Cedric; Oesterle, Tyler S; Karpyak, Victor M; Li, Hu; Weinshilboum, Richard M.
Affiliation
  • Ho MF; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • Zhang C; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • Moon I; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • Coombes BJ; Division of Computational Biology, Quantitative Health Sciences, Rochester, MN, United States.
  • Biernacka J; Division of Computational Biology, Quantitative Health Sciences, Rochester, MN, United States.
  • Skime M; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Choi DS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • Croarkin PE; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Ngo Q; Hazelden Betty Ford Foundation, Mayo Clinic, Center City, MN, United States.
  • Skillon C; Hazelden Betty Ford Foundation, Mayo Clinic, Center City, MN, United States.
  • Oesterle TS; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Karpyak VM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United States.
  • Li H; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
Front Pharmacol ; 13: 986238, 2022.
Article in En | MEDLINE | ID: mdl-36120372

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: United States Country of publication: Switzerland